HomeCompareMCK vs MA

MCK vs MA: Dividend Comparison 2026

MCK yields 0.38% · MA yields 0.64%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MA wins by $453.0K in total portfolio value
10 years
MCK
MCK
● Live price
0.38%
Share price
$860.19
Annual div
$3.28
5Y div CAGR
66.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$44.3K
Annual income
$10,761.37
Full MCK calculator →
MA
MA
● Live price
0.64%
Share price
$494.00
Annual div
$3.15
5Y div CAGR
91.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$497.2K
Annual income
$341,049.48
Full MA calculator →

Portfolio growth — MCK vs MA

📍 MA pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMCKMA
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MCK + MA cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MCK pays
MA pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MCK
Annual income on $10K today (after 15% tax)
$32.41/yr
After 10yr DRIP, annual income (after tax)
$9,147.16/yr
MA
Annual income on $10K today (after 15% tax)
$54.20/yr
After 10yr DRIP, annual income (after tax)
$289,892.06/yr
At 15% tax rate, MA beats the other by $280,744.89/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MCK + MA for your $10,000?

MCK: 50%MA: 50%
100% MA50/50100% MCK
Portfolio after 10yr
$270.7K
Annual income
$175,905.42/yr
Blended yield
64.97%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MA right now

MCK
Analyst Ratings
1
Strong
24
Buy
6
Hold
Consensus: Buy
Price Target
$982.38
+14.2% upside vs current
Range: $900.00 — $1,085.00
Altman Z
5.9
Piotroski
7/9
MA
Analyst Ratings
1
Strong
51
Buy
12
Hold
Consensus: Buy
Price Target
$667.33
+35.1% upside vs current
Range: $610.00 — $739.00
Altman Z
9.7
Piotroski
8/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MCK buys
0
MA buys
8
PoliticianChamberTickerTypeAmountDate
Sheldon Whitehouse🏛 Senate$MA▼ Sell$1,001 - $15,0002026-02-23
Markwayne Mullin🏛 Senate$MA▲ Buy$50,001 - $100,0002025-12-29
Markwayne Mullin🏛 Senate$MA▲ Buy$50,001 - $100,0002025-12-29
Michael McCaul🏢 House$MA▼ Sell$1,001 - $15,0002025-10-27
Gilbert Cisneros🏢 House$MA▲ Buy$1,001 - $15,0002025-10-17
Val Hoyle🏢 House$MA▼ Sell$1,001 - $15,0002025-09-23
Ro Khanna🏢 House$MA▲ Buy$1,000 - $15,0002025-08-04
Lisa McClain🏢 House$MA▼ Sell$1,001 - $15,0002025-06-24
Lisa McClain🏢 House$MA▲ Buy$1,001 - $15,0002025-06-17
Michael McCaul🏢 House$MA▼ Sell$15,001 - $50,0002025-06-16
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMCKMA
Forward yield0.38%0.64%
Annual dividend / share$3.28$3.15
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR66.7%91.8%
Portfolio after 10y$44.3K$497.2K
Annual income after 10y$10,761.37$341,049.48
Total dividends collected$22.6K$463.2K
Payment frequencyquarterlyquarterly
SectorHealthcareFinancials
Analyst consensusBuyBuy
Analyst price target$982.38$667.33

Year-by-year: MCK vs MA ($10,000, DRIP)

YearMCK PortfolioMCK Income/yrMA PortfolioMA Income/yrGap
1← crossover$10,764$63.56$10,822$122.30$58.00MA
2$11,624$106.59$11,817$237.26$193.00MA
3$12,617$179.33$13,109$464.38$492.00MA
4$13,803$303.26$14,950$923.39$1.1KMA
5$15,286$516.89$17,884$1,887.66$2.6KMA
6$17,248$891.81$23,183$4,047.78$5.9KMA
7$20,023$1,567.70$34,212$9,405.89$14.2KMA
8$24,260$2,835.35$61,488$24,880.97$37.2KMA
9$31,310$5,352.05$145,949$80,157.01$114.6KMA
10$44,263$10,761.37$497,215$341,049.48$453.0KMA

MCK vs MA: Complete Analysis 2026

MCKHealthcare

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The International segment offers distribution and services to wholesale, institutional, and retail customers in 13 European countries and Canada. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The RxTS segment serves biopharma and life sciences partners and patients to address medication challenges for patients throughout their journeys; connects pharmacies, providers, payers, and biopharma companies to deliver innovative access and adherence solutions; and provides third-party logistics and wholesale distribution support solutions. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.

Full MCK Calculator →

MAFinancials

Mastercard Incorporated, a technology company, provides transaction processing and other payment-related products and services in the United States and internationally. It facilitates the processing of payment transactions, including authorization, clearing, and settlement, as well as delivers other payment-related products and services. The company offers integrated products and value-added services for account holders, merchants, financial institutions, businesses, governments, and other organizations, such as programs that enable issuers to provide consumers with credits to defer payments; prepaid programs and management services; commercial credit and debit payment products and solutions; and payment products and solutions that allow its customers to access funds in deposit and other accounts. It also provides value-added products and services comprising cyber and intelligence solutions for parties to transact, as well as proprietary insights, drawing on principled use of consumer, and merchant data services. In addition, the company offers analytics, test and learn, consulting, managed services, loyalty, processing, and payment gateway solutions for e-commerce merchants. Further, it provides open banking and digital identity platforms services. The company offers payment solutions and services under the MasterCard, Maestro, and Cirrus. Mastercard Incorporated was founded in 1966 and is headquartered in Purchase, New York.

Full MA Calculator →
📬

Get this MCK vs MA comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MCK vs SCHDMCK vs JEPIMCK vs OMCK vs KOMCK vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.